- AdventHealth Research Institute
For decades, Type 1 diabetes (T1D) was perceived as a condition that appeared suddenly, transforming a person's life overnight. However, recent research is uncovering a different reality. Scientists have found that T1D develops gradually, often over several years, as the body's immune system begins to attack the insulin-producing cells in the pancreas. This important discovery has paved the way for an extraordinary possibility: the potential for prevention.
At AdventHealth’s Translational Research Institute (TRI) and centers across the country, researchers, scientists, and clinicians are studying ways to identify T1D before symptoms even appear. Through simple blood tests that look for autoantibodies, markers that show the immune system is active against insulin-producing cells, researchers can now detect the earliest signs of the disease, sometimes years before diagnosis.
This early detection means intervention is finally possible. Ongoing studies are exploring new treatments that could protect the pancreas, slow the immune attack, or even stop it entirely. It’s a radical shift moving from waiting to treat diabetes after it develops to finding ways to keep it from starting at all.
For families, that message brings hope. For those who already live with T1D, it means a future where children and grandchildren might never have to face it. For those at risk, it means having time to prepare, monitor, and participate in prevention studies that could make a lasting difference.
What You Can Do This Diabetes Awareness Month
1. Learn your risk.
If someone in your family has T1D, you can get screened for diabetes-related autoantibodies. These tests can reveal your risk level long before symptoms begin.
2. Pay attention to symptoms.
Excessive thirst, frequent urination, fatigue, or unexpected weight loss can all be early signs of diabetes. If you or your child experiences these, see a healthcare provider right away.
3. Support research.
Clinical studies rely on volunteers, both those with and without diabetes, to advance prevention and treatment. Participating or donating helps fuel discoveries that bring us closer to a world without T1D.
4. Share what you learn.
Awareness starts with conversation. Sharing accurate information about prevention and early testing could help someone you know detect diabetes before it becomes dangerous.
Prevention is no longer a far-off dream. Scientists are learning how to recognize T1D before it takes hold, and families are stepping up to be part of that change. Every test, every trial, every conversation brings us closer to a future where T1D may never have a chance to begin.
Recent News
Advancing Heart Care: A New Chapter with the BrioVAD Study
The AdventHealth Research team recently completed Core Training for the INNOVATE 2254936 Vidic trial, bringing this novel device to AdventHealth.
AdventHealth Launches NIH-Funded THRIVE Trial to Address Apathy in Late-Life Depression
AdventHealth Neuroscience Institute is launching THRIVE, a new NIH-funded clinical trial led by geriatric neuropsychologist and neuroscience researcher Lauren Oberlin, PhD.
AdventHealth Leads the Nation in STAR Trial Enrollment
AdventHealth Research Institute (AHRI) is proud to be the highest enrolling site in the United States for the STAR trial.
Gut Microbes, Diet, and Energy: New Clues for Tackling Energy Balance
A controlled dietary study found that a high-fiber, microbiome-enhancing diet altered gut metabolites, reduced energy absorption, and unexpectedly mimicked fasting effects, offering new insights into...
Can Exercise Turn Back the Clock on Your Brain? New Study Says Yes
What if hitting the gym could actually make your brain younger? A new study suggests it can. Our research group found that adults who committed to a year of moderate-to-vigorous aerobic exercise—like...
Dr. Kirk Erickson Featured on Fox 35 to Talk About the Connection Between Physical Activity and Brain Health
AdventHealth Research Institutes own Dr. Kirk Erickson was recently featured on Fox 35 to talk about the connection between physical activity and brain health.
Conform Trial: Major Milestone Achieved
On August 8, 2025, our team successfully completed the very first implant day for the Conform Clinical Trial, enrolling and treating our first three patients with the Conformal CLAAS System for Left...
Dr. Vipul Patel Performs the Longest Distance Telesurgery Ever Completed
In our latest Clinician’s View, Dr. Patel shares his team’s telesurgery journey, including how they are ensuring safety, quality and ethical exploration of this innovative approach.
AdventHealth’s Dr. Stephanie Compton Featured in ACS Highlight on Diet and Cancer Treatment
We’re proud to announce that Stephanie Compton, PhD, a valued post‑doctoral researcher at the AdventHealth Research Institute, was recently featured by the American Cancer Society.
Back-to-School with Type 1 Diabetes
Starting school is exciting and for families managing T1D, a little planning can make all the difference.
New Study Enrolling: RISE - Treating Ulcerative Colitis
We are proud to announce the launch of the new RISE study.
New Study Enrolling: SOMMA - Muscle, Mobility, and Aging Research
The adventHealth is excited to announce the launch of the SOMMA study. This study aims to better understand how our muscles and mobility function change as we age.